Grant Pickering Vaxcyte, Inc. (PCVX) insider trading activity

Grant Pickering is CHIEF EXECUTIVE OFFICER of Vaxcyte, Inc.. Currently has a direct ownership of 500,908 shares of PCVX, which is worth approximately $21.4 Million. The most recent transaction as insider was on Jun 24, 2022, when has been sold 747 shares (Common Stock) at a price of $21.01 per share, resulting in proceeds of $15,694. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 501K

3.44% 3M change

11.26% 12M change

Total Value Held $21.4 Million

GRANT PICKERING Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 24 2022	SELL Open market or private sale	$15,694 $21.01 p/Share	747 Reduced 0.11%	694,456 Common Stock
Jun 23 2022	SELL Open market or private sale	$74,396 $21.01 p/Share	3,541 Reduced 0.51%	695,203 Common Stock
Jun 22 2022	SELL Open market or private sale	$26,494 $21.01 p/Share	1,261 Reduced 0.18%	698,744 Common Stock
Jun 21 2022	SELL Open market or private sale	$114,744 $21.05 p/Share	5,451 Reduced 0.77%	700,005 Common Stock
May 16 2022	SELL Open market or private sale	$264,220 $24.02 p/Share	11,000 Reduced 1.54%	703,894 Common Stock
May 16 2022	BUY Exercise of conversion of derivative security	$19,690 $1.79 p/Share	11,000 Added 1.52%	714,894 Common Stock
Apr 18 2022	SELL Open market or private sale	$263,780 $23.98 p/Share	11,000 Reduced 1.54%	703,894 Common Stock
Apr 18 2022	BUY Exercise of conversion of derivative security	$19,690 $1.79 p/Share	11,000 Added 1.52%	714,894 Common Stock
Mar 22 2022	SELL Open market or private sale	$189,869 $24.62 p/Share	7,712 Reduced 1.08%	703,894 Common Stock
Mar 22 2022	BUY Exercise of conversion of derivative security	$13,804 $1.79 p/Share	7,712 Added 1.07%	711,606 Common Stock
Mar 21 2022	SELL Open market or private sale	$361,486 $25.3 p/Share	14,288 Reduced 1.99%	703,894 Common Stock
Mar 21 2022	BUY Exercise of conversion of derivative security	$25,576 $1.79 p/Share	14,288 Added 1.95%	718,182 Common Stock
Mar 02 2022	BUY Grant, award, or other acquisition	-	71,875 Added 9.27%	703,894 Common Stock
Dec 27 2021	BUY Exercise of conversion of derivative security	$98,871 $1.91 p/Share	51,765 Added 7.57%	632,019 Common Stock
Nov 19 2021	SELL Open market or private sale	$353,250 $23.55 p/Share	15,000 Reduced 2.52%	580,254 Common Stock
Nov 19 2021	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.46%	595,254 Common Stock
Oct 20 2021	SELL Open market or private sale	$343,050 $22.87 p/Share	15,000 Reduced 2.52%	580,254 Common Stock
Oct 20 2021	BUY Exercise of conversion of derivative security	$26,850 $1.79 p/Share	15,000 Added 2.46%	595,254 Common Stock
Sep 22 2021	SELL Open market or private sale	$105,622 $25.19 p/Share	4,193 Reduced 0.72%	580,254 Common Stock
Sep 22 2021	BUY Exercise of conversion of derivative security	$7,505 $1.79 p/Share	4,193 Added 0.71%	584,447 Common Stock
Sep 21 2021	SELL Open market or private sale	$275,903 $25.53 p/Share	10,807 Reduced 1.83%	580,254 Common Stock
Sep 21 2021	BUY Exercise of conversion of derivative security	$19,345 $1.79 p/Share	10,807 Added 1.8%	591,061 Common Stock
Aug 23 2021	SELL Open market or private sale	$313,293 $22.92 p/Share	13,669 Reduced 2.3%	580,254 Common Stock
Aug 23 2021	BUY Exercise of conversion of derivative security	$24,468 $1.79 p/Share	13,669 Added 2.25%	593,923 Common Stock
Aug 19 2021	SELL Open market or private sale	$29,814 $22.4 p/Share	1,331 Reduced 0.23%	580,254 Common Stock

Also insider at

ATHA

Athira Pharma, Inc. Healthcare

Grant Pickering

CHIEF EXECUTIVE OFFICER

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCVX shares.

Notify only if

Value

Insider Trading

Get notified when an Vaxcyte, Inc. insider buys or sells PCVX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Vaxcyte, Inc.

Track Activities on PCVX

Account